SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001839882-23-034399
Filing Date
2023-12-21
Accepted
2023-12-21 12:31:02
Documents
14
Period of Report
2023-12-15
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT dmk-8k_121523.htm   iXBRL 8-K 32286
2 PRESS RELEASE ex99-1.htm EX-99.1 11965
6 GRAPHIC dmk_001.jpg GRAPHIC 12151
  Complete submission text file 0001839882-23-034399.txt   240567

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE dmk-20231215.xsd EX-101.SCH 3051
4 XBRL LABEL FILE dmk-20231215_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE dmk-20231215_pre.xml EX-101.PRE 22384
8 EXTRACTED XBRL INSTANCE DOCUMENT dmk-8k_121523_htm.xml XML 3296
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
DMK PHARMACEUTICALS Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 231504019
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)